WeVote
Log In

Bill

Bill

HB 2964

cancer screening; coverage; gene mutation

57th Legislature - Second Regular Session Introduced by Lorena Austin and 17 co-sponsors

Arizona bill requiring health insurers to cover genetic cancer screening tests for hereditary cancer risk mutations, expanding preventive care mandates.

House Second Reading
0
WeVote Research Nonpartisan
Bill Summary · HB 2964

Legislative bill overview

HB 2964 requires health insurance coverage for cancer screening tests that identify gene mutations associated with increased cancer risk. The bill expands preventive care requirements by mandating insurers cover genetic testing for hereditary cancer predisposition syndromes, likely including tests for BRCA mutations and similar markers.

Why is this important

Early identification of cancer-predisposing gene mutations enables individuals to pursue preventive measures, increased monitoring, or preventive surgery—potentially saving lives and reducing advanced-stage cancer treatment costs. However, this creates new insurance coverage mandates that may increase premiums and limit insurers' ability to manage costs.

Potential points of contention

  • Cost and premium impact: Expanding mandatory coverage increases insurer expenses, potentially raising premiums for all policyholders; debate exists over whether genetic screening benefits justify the cost burden
  • Medical necessity and scope: Disagreement over which genetic tests qualify, who should be eligible (family history requirements vs. universal screening), and whether Arizona should set its own coverage standards
  • Access equity: While expanding coverage helps insured populations, it may increase disparities between insured and uninsured Arizonans, and raises questions about genetic testing access in underserved communities

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.